Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Feldman

Showing results (251-260 of 2,203) with videos related to

Pageof 221
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|June 3, 2010
Vitamine D analogue-based therapies for psoriasisJ L O'Neill, S R Feldman
The Journal of Dermatological Treatment|October 28, 2017
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?Kevin K Veverka, Steven R Feldman
Nature Clinical Practice. Oncology|July 20, 2007
Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trialsDarren R Feldman, George J Bosl
Journal of the American Academy of Dermatology|October 12, 2024
Response to deucravacitinib in psoriasis patients with prior biologic therapy failures: A retrospective studyKatie K Lovell, Steven R Feldman
Southern Medical Journal|May 15, 2015
Moving Away from Fee-for-Service: Implications for Medication AdherenceMichael E Farhangian, Steven R Feldman
JAAD International|August 19, 2021
Assessing the effect of demographic background on willingness to initiate a biologicJeremy K Bray, Steven R Feldman
Annals of the Rheumatic Diseases|February 15, 2005
Psoriasis assessment tools in clinical trialsS R Feldman, G G Krueger
Journal of Drugs in Dermatology : JDD|June 4, 2011
How patients experience and manage dryness and irritation from acne treatmentSteven R Feldman, Diana M Chen
Pediatric Dermatology|May 28, 2011
We must think outside the box to understand nonadherenceTushar S Dabade, Steven R Feldman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 19, 2019
Commentary on Surgical Volume of Dermatologists Who Do Not Perform Mohs Micrographic Dermatologic SurgerySteven R Feldman, Laura Buchanan Doerfler
Pageof 221

Showing results (251-260 of 2,203) with videos related to

Sort By:
Pageof 221
Drugs of Today (Barcelona, Spain : 1998)|June 3, 2010
Vitamine D analogue-based therapies for psoriasisJ L O'Neill, S R Feldman
The Journal of Dermatological Treatment|October 28, 2017
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?Kevin K Veverka, Steven R Feldman
Nature Clinical Practice. Oncology|July 20, 2007
Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trialsDarren R Feldman, George J Bosl
Journal of the American Academy of Dermatology|October 12, 2024
Response to deucravacitinib in psoriasis patients with prior biologic therapy failures: A retrospective studyKatie K Lovell, Steven R Feldman
Southern Medical Journal|May 15, 2015
Moving Away from Fee-for-Service: Implications for Medication AdherenceMichael E Farhangian, Steven R Feldman
JAAD International|August 19, 2021
Assessing the effect of demographic background on willingness to initiate a biologicJeremy K Bray, Steven R Feldman
Annals of the Rheumatic Diseases|February 15, 2005
Psoriasis assessment tools in clinical trialsS R Feldman, G G Krueger
Journal of Drugs in Dermatology : JDD|June 4, 2011
How patients experience and manage dryness and irritation from acne treatmentSteven R Feldman, Diana M Chen
Pediatric Dermatology|May 28, 2011
We must think outside the box to understand nonadherenceTushar S Dabade, Steven R Feldman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 19, 2019
Commentary on Surgical Volume of Dermatologists Who Do Not Perform Mohs Micrographic Dermatologic SurgerySteven R Feldman, Laura Buchanan Doerfler
Pageof 221